OSAKA, Japan — (BUSINESS WIRE) — Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced Shionogi Inc., a New Jersey-based subsidiary of Shionogi, has been awarded a $375 million project agreement through the Rapid
Published study reports near distance reading ability increased from 28.6% to 97.1% FAR HILLS, N.J. — (BUSINESS WIRE) — #AMD — Samsara Vision, a company focused on bringing vision and freedom back to patients with late-stage, age-related macular degeneration (AMD)
Components will be the first-in-human use of OSTAGUARD™ PRINCETON, N.J. — (BUSINESS WIRE) — Orthobond Corporation, a leader in covalently-bound antibacterial surface technologies with broad applications in the medical device industry, today announced the successful in-house production and commercial delivery
Dazed, the fastest growing cannabis brand on the East Coast and 5th LEGAL dispensary to open in NYC, is seeing their customers embrace the growing trend of California Sober. The increasingly popular lifestyle that allows for cannabis indulgences but opts out
Leading Southern California clinics join Premier North American Fertility Network BASKING RIDGE, N.J. — (BUSINESS WIRE) — IVI RMA North America, a leader in fertility care and assisted reproduction, Tuesday announced it completed the acquisition of three prominent Southern California-based fertility
NEWARK, N.J. — (BUSINESS WIRE) — Fabuwood is proud to announce the launch of its newest cabinet stain, Mocha, an inviting color that perfectly balances warmth and sophistication. As one of the most highly anticipated and requested stains, Mocha joins Fabuwood’s popular
LAKEWOOD, N.J. — (BUSINESS WIRE) — Knipper Health, Inc., the largest supplier of end-to-end pharmaceutical healthcare marketing services and solutions in the U.S. serving the biopharmaceutical and medical industries, announced today the Company has been assigned the assets of Patheon Pharma Services
Transaction expected to close in the coming days SOMERSET, N.J. & COPENHAGEN, Denmark — (BUSINESS WIRE) — Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S (“Novo
Ad hoc announcement pursuant to Art. 53 LR Newron will receive up to a maximum of €117 million from an upfront payment, development milestones and commercialization milestones, and up to double-digit tiered royalties on net sales Evenamide is a unique modulator of